| Literature DB >> 33376741 |
Emrah Beyan1, Abdurrahman H İnan1, Volkan Emirdar2, Adnan Budak1, Sadettin O Tutar3, Ahkam G Kanmaz1.
Abstract
It is known that benign gynecological diseases negatively affect sexual function. For this reason, hysterectomy provides improvement in sexual function as well as symptoms such as bleeding and pain. The effects of abdominal hysterectomy (TAH) and laparoscopic hysterectomy (TLH), which are the two most common types of hysterectomy today, are not clear. In our study, we investigated the effects of TAH and TLH on sexual function and quality of life as well as intraoperative and postoperative results. In 329 TLH and 126 TAH patients, we compared both and between themselves preoperatively and postoperatively by using the standardized and validated female sexual function index (FSFI) and European quality of life five-dimension scale (EQ-5D). In conclusion, we found that both types of hysterectomy were effective in improving sexual function, and we concluded that improvement in the laparoscopy group was statistically higher. Patients who require hysterectomy for benign gynecological reasons should be informed that TLH has a more positive effect on sexual function as well as other advantages, and if the patients' main complaint is sexual dysfunction, TLH should be preferred compared to TAH.Entities:
Mesh:
Year: 2020 PMID: 33376741 PMCID: PMC7738778 DOI: 10.1155/2020/8247207
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Baseline characteristics of patients and indication for surgery.
| Characteristics | TLH ( | TAH ( |
|
|---|---|---|---|
| Age (y) | 46.4 ± 5.9 | 46.9 ± 6.1 | 0.423 |
| BMI (kg/m2) | 23.7 ± 3.1 | 23.4 ± 2.8 | 0.344 |
| Uterine volume | |||
| Normal size | 83 (25.2%) | 33 (26.2%) | 0.833 |
| 6-8 weeks gestational size | 59 (17.9%) | 21 (16.6%) | 0.751 |
| 8-10 weeks gestational size | 98 (29.8%) | 34 (27.0%) | 0.555 |
| 10-12 weeks gestational size | 44 (13.4%) | 18 (14.3%) | 0.800 |
| 12-14 weeks gestational size | 26 (7.9%) | 11 (8.7%) | 0.773 |
| >14 weeks gestational size | 19 (5.8%) | 9 (7.2%) | 0.587 |
| Prior cesarean delivery | 63 (19.1%) | 26 (20.6%) | 0.721 |
| Previously undergone abdominal surgery | 37 (11.2%) | 16 (12.7%) | 0.666 |
| Medical comorbidities | 60 (18.2%) | 22 (17.5%) | 0.847 |
| Indication | |||
| Myoma uteri | 215 (65.3%) | 83 (65.9%) | 0.916 |
| DUB | 61 (18.5%) | 22 (17.5%) | 0.789 |
| Endometrial hyperplasia | 23 (7.0%) | 9 (7.1%) | 0.955 |
| Adenomyosis | 15 (4.6%) | 6 (4.7%) | 0.927 |
| CIN3 | 15 (4.6%) | 6 (4.7%) | 0.927 |
TLH: total laparoscopic hysterectomy; TAH: total abdominal hysterectomy; BMI: body mass index; DUB: dysfunctional uterine bleeding; CIN3: cervical intraepithelial neoplasia grade III.
Operative and postoperative variables of TLH group vs. TAH group.
| Variables | TLH ( | TAH ( |
|
|---|---|---|---|
| OT (min) | 100.4 ± 28.1 | 95.6 ± 30.4 | 0.112 |
| EBL (mL) | 160.5 ± 132.8 | 285.9 ± 156.2 | <0.001 |
| The number of patients that required analgesics ( | 55 | 54 | <0.001 |
| Days with indwelling catheter (day) | 0.8 ± 0.4 | 1.5 ± 0.6 | <0.001 |
| Passing flatus (hour) | 20.8 ± 12.8 | 28.6 ± 16.5 | <0.001 |
TLH: total laparoscopic hysterectomy; TAH: total abdominal hysterectomy; OT: operative time; EBL: estimated blood loss.
Intraoperative and postoperative complications of TLH group vs. TAH group.
| Complications | TLH ( | TAH ( |
|
|---|---|---|---|
| Total types of intraoperative complications | 13 (3.9%) | 7 (5.5%) | 0.455 |
| Bladder or ureter injuries | 7 (2.1%) | 3 (2.4%) | |
| Bowel injuries | 2 (0.6%) | 2 (1.6%) | |
| Vascular injuries | 2 (0.6%) | 2 (1.6%) | |
| Subcutaneous emphysema | 2 (0.6%) | – | |
| Total types of postoperative complications | 10 (3.0%) | 12 (9.5%) | 0.004 |
| Febrile event | 3 (0.9%) | 3 (2.4%) | |
| Wound infection | 1 (0.3%) | 2 (1.6%) | |
| Bleeding or hematoma | 1 (0.3%) | 2 (1.6%) | |
| Urinary retention | 2 (0.6%) | 1 (0.7%) | |
| Ileus | 1 (0.3%) | 2 (1.6%) | |
| UTI | 2 (0.6%) | 2 (1.6%) |
TLH: total laparoscopic hysterectomy; TAH: total abdominal hysterectomy; UTI: urinary tract infection.
Outcomes of FSFI, EQ-5D (TTO), and VAS.
| Characteristics | TLH ( | TAH ( |
|
|---|---|---|---|
| FSFI | |||
| Preoperative | 18.87 ± 6.63 | 17.89 ± 5.87 | 0.203 |
| Postoperative | 21.65 ± 5.42 | 19.35 ± 4.62 | <0.001 |
| Difference | 2.78 ± 5.65 | 1.46 ± 4.97 | 0.044 |
| Difference | <0.001 | 0.057 | |
| EQ-5D (TTO) | |||
| Preoperative | 0.79 ± 0.19 | 0.71 ± 0.21 | <0.001 |
| Postoperative | 0.86 ± 0.21 | 0.85 ± 0.16 | 0.672 |
| Difference | 0.07 ± 0.19 | 0.14 ± 0.18 | 0.002 |
| Difference | <0.001 | <0.001 | |
| VAS | |||
| Preoperative | 63.22 ± 25.93 | 60.61 ± 23.37 | 0.388 |
| Postoperative | 81.27 ± 17.64 | 80.59 ± 17.12 | 0.745 |
| Difference | 18.05 ± 31.71 | 19.98 ± 27.61 | 0.599 |
| Difference | <0.001 | <0.001 |
TLH: total laparoscopic hysterectomy; TAH: total abdominal hysterectomy; FSFI: Female Sexual Functioning Index; EQ-5D: European quality of life five-dimension scale; VAS: vertical visual analog scale.
Outcomes of FSFI subcategories.
| FSFI subcategories | TLH ( | TAH ( |
|
|---|---|---|---|
| Desire | |||
| Preoperative | 2.87 ± 1.26 | 2.70 ± 1.11 | 0.245 |
| Postoperative | 3.54 ± 1.25 | 2.81 ± 1.36 | <0.001 |
| Difference | 0.67 ± 1.58 | 0.11 ± 1.28 | 0.002 |
| Difference | <0.001 | 0.540 | |
| Arousal | |||
| Preoperative | 3.16 ± 1.77 | 2.93 ± 1.79 | 0.279 |
| Postoperative | 3.86 ± 1.73 | 3.10 ± 1.88 | <0.001 |
| Difference | 0.70 ± 2.04 | 0.17 ± 1.61 | 0.022 |
| Difference | <0.001 | 0.522 | |
| Lubrication | |||
| Preoperative | 2.49 ± 1.25 | 2.27 ± 1.19 | 0.137 |
| Postoperative | 2.56 ± 1.06 | 2.37 ± 1.08 | 0.136 |
| Difference | 0.07 ± 1.06 | 0.10 ± 0.98 | 0.809 |
| Difference | 0.492 | 0.543 | |
| Orgasm | |||
| Preoperative | 2.82 ± 1.64 | 2.59 ± 1.75 | 0.250 |
| Postoperative | 3.19 ± 1.46 | 2.64 ± 1.52 | 0.002 |
| Difference | 0.37 ± 1.64 | 0.05 ± 1.40 | 0.091 |
| Difference | 0.007 | 0.833 | |
| Satisfaction | |||
| Preoperative | 3.61 ± 1.89 | 3.54 ± 1.99 | 0.760 |
| Postoperative | 4.12 ± 1.89 | 3.74 ± 1.75 | 0.870 |
| Difference | 0.51 ± 2.01 | 0.20 ± 1.52 | 0.171 |
| Difference | 0.002 | 0.461 | |
| Pain | |||
| Preoperative | 2.53 ± 1.12 | 2.32 ± 1.21 | 0.126 |
| Postoperative | 4.11 ± 2.21 | 3.85 ± 1.01 | 0.268 |
| Difference | 1.58 ± 1.76 | 1.53 ± 1.51 | 0.805 |
| Difference | <0.001 | <0.001 | |
TLH: total laparoscopic hysterectomy; TAH: total abdominal hysterectomy; FSFI: Female Sexual Functioning Index.